DK0720595T3 - Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation - Google Patents

Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation

Info

Publication number
DK0720595T3
DK0720595T3 DK94928427T DK94928427T DK0720595T3 DK 0720595 T3 DK0720595 T3 DK 0720595T3 DK 94928427 T DK94928427 T DK 94928427T DK 94928427 T DK94928427 T DK 94928427T DK 0720595 T3 DK0720595 T3 DK 0720595T3
Authority
DK
Denmark
Prior art keywords
pct
enantiomer
solution
sec
mother liquors
Prior art date
Application number
DK94928427T
Other languages
English (en)
Inventor
Roger Bouaziz
Gerard Coquerel
Marie-Noelle Petit
Original Assignee
Univ Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rouen filed Critical Univ Rouen
Application granted granted Critical
Publication of DK0720595T3 publication Critical patent/DK0720595T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/78Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by condensation or crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94928427T 1993-09-23 1994-09-22 Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation DK0720595T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9311354A FR2710337B1 (fr) 1993-09-23 1993-09-23 Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé.
PCT/FR1994/001107 WO1995008522A1 (fr) 1993-09-23 1994-09-22 Procede de dedoublement de deux antipodes optiques par cristallisation

Publications (1)

Publication Number Publication Date
DK0720595T3 true DK0720595T3 (da) 1999-08-23

Family

ID=9451175

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928427T DK0720595T3 (da) 1993-09-23 1994-09-22 Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation

Country Status (9)

Country Link
US (1) US6022409A (da)
EP (1) EP0720595B1 (da)
JP (1) JP3647862B2 (da)
AT (1) ATE174889T1 (da)
DE (1) DE69415545T2 (da)
DK (1) DK0720595T3 (da)
ES (1) ES2128584T3 (da)
FR (1) FR2710337B1 (da)
WO (1) WO1995008522A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7501514B1 (en) 2003-10-15 2009-03-10 Shire Biochem, Inc. Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides
DE102005039501B4 (de) 2005-08-20 2013-09-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Trennung verbindungsbildender chiraler Systeme
JP2010503677A (ja) 2006-09-15 2010-02-04 シェーリング コーポレイション 脂質代謝の障害を治療するためのアゼチジノン誘導体
US20080070890A1 (en) * 2006-09-15 2008-03-20 Burnett Duane A Spirocyclic Azetidinone Compounds and Methods of Use Thereof
FR2909380B1 (fr) 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
ES2421708T3 (es) * 2008-09-05 2013-09-05 Shire Canada Inc Resolución enantiomérica de nucleósidos de 1,3-oxatiolano 2,4-disustituidos
WO2010025968A2 (en) 2008-09-05 2010-03-11 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. Process for enantioseparation of chiral systems with compound formation using two subsequent crystallization steps
WO2010109015A1 (en) 2009-03-26 2010-09-30 Poxel Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization
EP2292306B1 (en) * 2009-09-02 2013-05-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for separation of racemic compound-forming chiral substances by a cyclic crystallization process and a crystallization device
FR2954310B1 (fr) 2009-12-18 2014-07-25 Univ Rouen Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle
FR3054218B1 (fr) * 2016-07-22 2020-03-06 Universite De Rouen Procede de dedoublement de sels de baclofene
WO2020191163A1 (en) 2019-03-20 2020-09-24 Regeneron Pharmaceuticals, Inc. Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (scap) inhibitors
US11504390B2 (en) 2019-03-20 2022-11-22 Regeneron Pharmaceuticals, Inc. Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1456627A (fr) * 1964-07-24 1966-07-08 Asahi Chemical Ind Perfectionnements aux procédés pour la résolution de l'acide glutamique racémique et de ses sels
GB1197809A (en) * 1968-02-13 1970-07-08 Inst Noguchi Method for Continuous Optical Resolution of Organic Racemates.

Also Published As

Publication number Publication date
ES2128584T3 (es) 1999-05-16
WO1995008522A1 (fr) 1995-03-30
FR2710337A1 (fr) 1995-03-31
ATE174889T1 (de) 1999-01-15
EP0720595B1 (fr) 1998-12-23
US6022409A (en) 2000-02-08
JPH09506861A (ja) 1997-07-08
EP0720595A1 (fr) 1996-07-10
FR2710337B1 (fr) 1995-12-08
DE69415545D1 (de) 1999-02-04
JP3647862B2 (ja) 2005-05-18
DE69415545T2 (de) 1999-09-16

Similar Documents

Publication Publication Date Title
DK0720595T3 (da) Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation
ATE207036T1 (de) Herstellung von aluminosilikatzeolithen
DK289687A (da) Fremgangsmaade til fremstilling af l-2-amino-4-(hydroxymethylphosphinyl)-smoeresyre
ATE240139T1 (de) Co-kristallisationsprozess
FI924668A (fi) Foerfarande foer framstaellning av vaesentligen ren melfalanhydroklorid
ES8504683A1 (es) Procedimiento de obtencion de un par enantiomerico de isomeros de cihalotrina
DE3586017D1 (de) Stabiles glukose-isomerase-konzentrat und verfahren zu dessen herstellung.
RU2004137681A (ru) Аддукт топирамата и гидрохлорида трамадола и его применения
DE59405052D1 (de) Verfahren zum herstellen von granulat
DK122983A (da) Fremgangsmaade til fremstilling af isomaltulose (6-o-alfa-d-glucopyranosido-d-fructose) ved omdannelse af saccharose med immobiliserede bakterieceller
DK0759973T3 (da) Fremgangsmåde til klaring af vinase
JPS549174A (en) Method of producing seingle crystal
GEP19981257B (en) Method of producing crystalline enantiomeric pair of isomers of (s)-alpha-cyano-3-phenoxybenzyl ester of (1r,cis)-3-(z-3-chlor-3,3,3)-trifluorprop-1-en-1-yl-2,2-dimethylcyclopropionic acid and (r)-alpha-cyano-3-phenoxybenzyl ester of (1s,cis9-3-(z-2-chlor-3,3,3-trifluorprop-1-en-1yl))-2,2-dimethylcyclopropionic acid
ES386356A1 (es) Un procedimiento para cristalizar un componente cristaliza-ble a partir de una solucion del mismo.
KR850005404A (ko) α-시아노-3-펜옥시-4-플루오로벤질 퍼메트레이트의 특정 에난티오머쌍의 제조방법
DE3060670D1 (en) Process for the separation of the two optical isomers of 1-(o-methoxyphenoxy)-3-isopropylamino-propan-2-ol, optical isomers obtained thereby and pharmaceutical compositions of the levorotatory antipode thereof
US2602047A (en) Method of concentrating isotopic carbon
DE59309480D1 (de) Verfahren zur herstellung einer physikalisch stabilen, kristallinen gamma-modifikation von para-aminobenzolsulfonamid
JPS5373507A (en) Crystallization of pentaerythritol
JPS55115846A (en) Optical resolution of dl-mandelic acid
NZ239435A (en) Conversion of the r(-) isomer of ketoprofen to the s(+) isomer
JPS5413477A (en) Continuous growing apparatus for single crystal
GB1020696A (en) Resolution of a salt of n-benzoyl serine
JPS56158792A (en) Preparation of amineborane
TH52584B (th) กระบวนการสำหรับเตรียมรูปผลึกที่ i ของคาเบอร์โกลีน